Where I see patients (2)
Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory Decisions.
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Type 1 Diabetes Extension Study
Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC). C-peptide is released by the pancreas into the bloodstream in equal...